Abbott Laboratories (ABT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 25.51B | 26B | 24.84B | 24.47B | 23.15B | 23.66B | 23.8B | 23.12B | 22.38B | 22.67B | 22.66B | 23.5B |
| Cash & Short-Term Investments | 7.29B | 8.94B | 7.73B | 7.28B | 6.84B | 7.97B | 7.79B | 7.22B | 6.65B | 7.28B | 7.05B | 8.15B |
| Cash Only | 6.8B | 8.52B | 7.51B | 6.95B | 6.53B | 7.62B | 7.56B | 6.99B | 6.28B | 6.9B | 6.71B | 7.83B |
| Short-Term Investments | 492M | 417M | 222M | 331M | 312M | 351M | 230M | 232M | 367M | 383M | 338M | 320M |
| Accounts Receivable | 8.21B | 7.93B | 8.14B | 7.97B | 7.33B | 6.92B | 7.05B | 6.85B | 6.61B | 6.57B | 6.5B | 6.17B |
| Days Sales Outstanding | 65.05 | 64.5 | 65.18 | 62.48 | 61.92 | 58.58 | 60.14 | 59.01 | 60.14 | 58.68 | 57.46 | 55.6 |
| Inventory | 6.99B | 6.49B | 6.71B | 6.95B | 6.64B | 6.19B | 6.81B | 6.81B | 6.83B | 6.57B | 6.65B | 6.87B |
| Days Inventory Outstanding | 124.25 | 123.33 | 124.92 | 127.42 | 117.52 | 111.3 | 120.34 | 122.37 | 123.34 | 122.04 | 121.74 | 122.44 |
| Other Current Assets | 0 | 2.64B | 2.26B | 2.26B | 2.34B | 2.57B | 2.15B | 2.23B | 2.29B | 2.26B | 2.47B | 2.31B |
| Total Non-Current Assets | 84.92B | 60.72B | 59.34B | 59.53B | 58.3B | 57.76B | 50.55B | 49.9B | 50.09B | 50.54B | 49.43B | 49.85B |
| Property, Plant & Equipment | 12.38B | 12.94B | 11.5B | 11.39B | 10.93B | 11.73B | 10.62B | 10.23B | 10.11B | 11.28B | 9.55B | 9.45B |
| Fixed Asset Turnover | 0.88x | 0.94x | 0.99x | 1.00x | 0.91x | 0.98x | 1.02x | 1.02x | 0.93x | 0.98x | 1.07x | 1.07x |
| Goodwill | 35.22B | 24.04B | 23.97B | 23.95B | 23.36B | 23.11B | 23.66B | 23.31B | 23.38B | 23.68B | 23.28B | 23.26B |
| Intangible Assets | 17.88B | 5.53B | 5.6B | 5.92B | 6.26B | 6.65B | 7.35B | 7.83B | 8.3B | 8.81B | 9.28B | 9.83B |
| Long-Term Investments | 1.09B | 918M | 951M | 958M | 907M | 886M | 912M | 877M | 818M | 799M | 788M | 799M |
| Other Non-Current Assets | 18.36B | 17.3B | 17.32B | 17.31B | 16.84B | 15.38B | 8.01B | 7.65B | 7.49B | 5.97B | 6.53B | 6.51B |
| Total Assets | 110.43B | 86.71B | 84.18B | 84B | 81.45B | 81.41B | 74.36B | 73.02B | 72.47B | 73.21B | 72.09B | 73.35B |
| Asset Turnover | 0.11x | 0.13x | 0.14x | 0.13x | 0.13x | 0.14x | 0.14x | 0.14x | 0.14x | 0.14x | 0.14x | 0.14x |
| Asset Growth % | 35.58% | 6.51% | 13.21% | 15.04% | 12.39% | 11.2% | 3.14% | -0.46% | -1.8% | -1.64% | -0.98% | -1.14% |
| Total Current Liabilities | 18.38B | 16.5B | 14.58B | 13.44B | 13B | 14.16B | 14.9B | 13.76B | 14.02B | 13.84B | 13.04B | 14.35B |
| Accounts Payable | 4.68B | 4.24B | 4.12B | 4.31B | 4.21B | 4.2B | 4.03B | 4.13B | 4.18B | 4.29B | 3.96B | 4.21B |
| Days Payables Outstanding | 82.23 | 78.16 | 77.07 | 79.86 | 77.01 | 70.41 | 72.05 | 74.48 | 78.01 | 76.21 | 73.58 | 75.74 |
| Short-Term Debt | 4.41B | 3.31B | 1.34B | 507M | 506M | 1.75B | 2.15B | 1.61B | 2.01B | 1.32B | 1.05B | 2.28B |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 7.48B | 5.54B | 6.91B | 6.69B | 6.63B | 5.91B | 6.38B | 6.03B | 6.18B | 6.13B | 6.23B | 6.22B |
| Current Ratio | 1.39x | 1.58x | 1.70x | 1.82x | 1.78x | 1.67x | 1.60x | 1.68x | 1.60x | 1.64x | 1.74x | 1.64x |
| Quick Ratio | 1.01x | 1.18x | 1.24x | 1.30x | 1.27x | 1.23x | 1.14x | 1.18x | 1.11x | 1.16x | 1.23x | 1.16x |
| Cash Conversion Cycle | 107.08 | 109.67 | 113.03 | 110.03 | 102.43 | 99.47 | 108.43 | 106.9 | 105.47 | 104.5 | 105.63 | 102.3 |
| Total Non-Current Liabilities | 39.35B | 17.45B | 18.34B | 19.73B | 19.38B | 19.36B | 19.43B | 19.7B | 19.4B | 20.55B | 21.35B | 21.6B |
| Long-Term Debt | 29.64B | 10.83B | 11.6B | 12.93B | 12.74B | 12.63B | 12.82B | 13.14B | 12.58B | 13.6B | 14.48B | 14.56B |
| Capital Lease Obligations | 0 | 931M | 0 | 0 | 0 | 896M | 0 | 0 | 0 | 949M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 1.96B | 0 | 0 | 0 | 1.37B | 0 | 0 | 0 | 1.22B | 0 | 0 |
| Other Non-Current Liabilities | 9.71B | 3.73B | 6.74B | 6.8B | 6.64B | 4.46B | 6.6B | 6.56B | 6.83B | 4.78B | 6.88B | 7.04B |
| Total Liabilities | 57.73B | 33.94B | 32.92B | 33.17B | 32.38B | 33.51B | 34.33B | 33.46B | 33.42B | 34.39B | 34.4B | 35.95B |
| Total Debt | 34.05B | 15.07B | 12.94B | 13.44B | 13.24B | 15.28B | 14.98B | 14.75B | 14.59B | 15.87B | 15.53B | 16.85B |
| Net Debt | 27.24B | 6.54B | 5.43B | 6.49B | 6.71B | 7.66B | 7.42B | 7.77B | 8.3B | 8.98B | 8.82B | 9.01B |
| Debt / Equity | 0.65x | 0.29x | 0.25x | 0.26x | 0.27x | 0.32x | 0.37x | 0.37x | 0.37x | 0.41x | 0.41x | 0.45x |
| Debt / EBITDA | 13.24x | 5.64x | 4.54x | 4.75x | 5.42x | 5.46x | 5.72x | 5.92x | 6.66x | 5.93x | 6.21x | 7.29x |
| Net Debt / EBITDA | 10.59x | 2.45x | 1.91x | 2.29x | 2.75x | 2.74x | 2.83x | 3.12x | 3.79x | 3.35x | 3.52x | 3.90x |
| Interest Coverage | 22.31x | 20.00x | 52.30x | 18.77x | 14.27x | 14.36x | 12.69x | 10.57x | 13.27x | 8.64x | 12.29x | 11.69x |
| Total Equity | 52.7B | 52.77B | 51.26B | 50.83B | 49.06B | 47.9B | 40.03B | 39.56B | 39.04B | 38.83B | 37.69B | 37.4B |
| Equity Growth % | 7.41% | 10.17% | 28.07% | 28.49% | 25.67% | 23.37% | 6.19% | 5.76% | 4.86% | 5.21% | 5.04% | 1.87% |
| Book Value per Share | 30.17 | 30.21 | 29.31 | 29.03 | 28.08 | 27.43 | 22.90 | 22.59 | 22.31 | 22.21 | 21.56 | 21.37 |
| Total Shareholders' Equity | 52.06B | 52.13B | 50.95B | 50.56B | 48.81B | 47.66B | 39.8B | 39.32B | 38.81B | 38.6B | 37.48B | 37.17B |
| Common Stock | 25.35B | 25.53B | 25.41B | 25.28B | 25.13B | 25.15B | 25.02B | 24.86B | 24.73B | 24.87B | 24.73B | 24.61B |
| Retained Earnings | 49.96B | 49.78B | 49.1B | 48.47B | 47.72B | 47.26B | 39.06B | 38.35B | 38.01B | 37.55B | 36.92B | 36.35B |
| Treasury Stock | -16.93B | -17.18B | -16.88B | -16.61B | -16.61B | -16.84B | -16.48B | -15.76B | -15.76B | -15.98B | -15.69B | -15.72B |
| Accumulated OCI | -6.31B | -6B | -6.68B | -6.58B | -7.42B | -7.91B | -7.8B | -8.13B | -8.17B | -7.84B | -8.48B | -8.07B |
| Minority Interest | 640M | 641M | 310M | 264M | 253M | 237M | 232M | 242M | 233M | 224M | 213M | 230M |